ArticleFrontiers in oncology2026
Improving lung cancer screening in real-world settings: a pragmatic approach to provider education, barriers, and solutions.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lung cancer is the leading cause of cancer mortality in the United States. While lung cancer screening (LCS) with low-dose computed tomography (LDCT) has been shown to have a 20% relative reduction in mortality, the real-world benefit of screening has not been realized as screening of eligible individuals remains low. Primary care providers (PCPs) play a pivotal role in identifying eligible patients, initiating shared decision-making, and coordinating follow-up care, yet many report limited knowledge and confidence in implementing LCS. Provider education is a critical, scalable intervention to address these barriers and improve screening delivery in primary care. Pilot pragmatic trials are essential for evaluating real-world strategies to increase LCS uptake in primary care settings. Methods: We utilized a clinical advisory board of LCS experts to co-develop a 30-minute LCS education curriculum tailored for primary care providers (PCPs) at a safety-net hospital in Central Indiana and assessed its' impact on PCPs' knowledge of LCS guidelines, comfort with shared decision-making (SDM), communicating LDCT results, and confidence in managing post-screening care. Results: Following completion of the LCS education curriculum, primary care providers reported increased comfortability discussing LCS and LDCT results with their patients and increased familiarity with LCS eligibility criteria, which was reflected by improved application of screening guidelines to patient scenarios. LCS referrals by primary providers also increased following implementation of the LCS education curriculum. Discussion: Implementation of the LCS education curriculum led to improved provider comfort in discussing LCS with patients, confidence in managing next steps following LDCT results, increased knowledge of LCS eligibility, and application of screening criteria to patient scenarios, which was associated with an increased number of new referrals of eligible patients to the lung cancer screening program. Future aims can be developed to expand a LCS education curriculum beyond a single primary care clinic and digitize the curriculum into interactive modules, microlearning formats, and mobile-friendly platforms to enhance accessibility for providers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.